186 related articles for article (PubMed ID: 35897710)
1. Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn's Disease.
Alexdottir MS; Bourgonje AR; Karsdal MA; Pehrsson M; Loveikyte R; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Faber KN; Dijkstra G; Mortensen JH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897710
[TBL] [Abstract][Full Text] [Related]
2. Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn's Disease.
Alexdottir MS; Bourgonje AR; Karsdal MA; Pehrsson M; Loveikyte R; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Faber KN; Dijkstra G; Mortensen JH
Front Med (Lausanne); 2022; 9():933872. PubMed ID: 35903311
[TBL] [Abstract][Full Text] [Related]
3. Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease.
Bourgonje AR; Alexdottir MS; Otten AT; Loveikyte R; Bay-Jensen AC; Pehrsson M; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Karsdal MA; Faber KN; Mortensen JH; Dijkstra G
Aliment Pharmacol Ther; 2022 Aug; 56(4):675-693. PubMed ID: 35661188
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix turnover biomarkers reflect pharmacodynamic effects and treatment response of adalimumab in patients with axial spondyloarthritis-results from two randomized controlled trials.
Port H; Holm Nielsen S; Frederiksen P; Madsen SF; Bay-Jensen AC; Sørensen IJ; Jensen B; Loft AG; Madsen OR; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2023 Aug; 25(1):157. PubMed ID: 37626399
[TBL] [Abstract][Full Text] [Related]
5. A Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity.
Mortensen JH; Sinkeviciute D; Manon-Jensen T; Domislović V; McCall K; Thudium CS; Brinar M; Önnerfjord P; Goodyear CS; Krznarić Ž; Karsdal MA; Bay-Jensen AC
J Crohns Colitis; 2022 Sep; 16(9):1447-1460. PubMed ID: 35304895
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Biomarkers of Extracellular Matrix Remodeling and Disease Activity in Crohn's Disease and Ulcerative Colitis.
Domislovic V; Høg Mortensen J; Lindholm M; Kaarsdal MA; Brinar M; Barisic A; Manon-Jensen T; Krznaric Z
J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233775
[TBL] [Abstract][Full Text] [Related]
7. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
8. Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.
van Haaften WT; Mortensen JH; Karsdal MA; Bay-Jensen AC; Dijkstra G; Olinga P
Aliment Pharmacol Ther; 2017 Jul; 46(1):26-39. PubMed ID: 28481042
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Matrix Fragments of the Basement Membrane and the Interstitial Matrix Are Serological Markers of Intestinal Tissue Remodeling and Disease Activity in Dextran Sulfate Sodium Colitis.
Lindholm M; Manon-Jensen T; Madsen GI; Krag A; Karsdal MA; Kjeldsen J; Mortensen JH
Dig Dis Sci; 2019 Nov; 64(11):3134-3142. PubMed ID: 31123972
[TBL] [Abstract][Full Text] [Related]
10. Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot Study.
van Haaften WT; Mortensen JH; Dige AK; Grønbæk H; Hvas CL; Bay-Jensen AC; Karsdal MA; Olinga P; Manon-Jensen T; Dijkstra G
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00217. PubMed ID: 33094957
[TBL] [Abstract][Full Text] [Related]
11. Investigating protease-mediated peptides of inflammation and tissue remodeling as biomarkers associated with flares in psoriatic arthritis.
Groen SS; Nielsen SH; Bay-Jensen AC; Rasti M; Ganatra D; Oikonomopoulou K; Chandran V
Arthritis Res Ther; 2024 May; 26(1):107. PubMed ID: 38802975
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis.
Pehrsson M; de Rooij WE; Bay-Jensen AC; Karsdal MA; Mortensen JH; Bredenoord AJ
BMC Gastroenterol; 2023 Oct; 23(1):357. PubMed ID: 37845632
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients.
Jensen C; Madsen DH; Hansen M; Schmidt H; Svane IM; Karsdal MA; Willumsen N
J Immunother Cancer; 2018 Dec; 6(1):152. PubMed ID: 30567561
[TBL] [Abstract][Full Text] [Related]
14. Endotrophin and C6Ma3, serological biomarkers of type VI collagen remodelling, reflect endoscopic and clinical disease activity in IBD.
Lindholm M; Godskesen LE; Manon-Jensen T; Kjeldsen J; Krag A; Karsdal MA; Mortensen JH
Sci Rep; 2021 Jul; 11(1):14713. PubMed ID: 34282237
[TBL] [Abstract][Full Text] [Related]
15. Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers.
Port H; Christiansen F; Nielsen SH; Frederiksen P; Bay-Jensen AC; Karsdal MA; Seven S; Sørensen IJ; Loft AG; Madsen OR; Ostergaard M; Pedersen SJ
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38199849
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain.
Port H; Nielsen SH; Madsen SF; Bay-Jensen AC; Karsdal M; Seven S; Sørensen IJ; Morsel-Carlsen L; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2022 Jun; 24(1):152. PubMed ID: 35739562
[TBL] [Abstract][Full Text] [Related]
17. Levels of extracellular matrix metabolites are associated with changes in Ankylosing Spondylitis Disease Activity Score and MRI inflammation scores in patients with axial spondyloarthritis during TNF inhibitor therapy.
Holm Nielsen S; Sun S; Bay-Jensen AC; Karsdal M; Sørensen IJ; Weber U; Loft AG; Kollerup G; Thamsborg G; Madsen OR; Møller J; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2022 Dec; 24(1):279. PubMed ID: 36564778
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
Dobrota R; Jordan S; Juhl P; Del Papa N; Maurer B; Becker M; Mihai C; Bay-Jensen AC; Karsdal MA; Siebuhr AS; Distler O
RMD Open; 2024 May; 10(2):. PubMed ID: 38806188
[TBL] [Abstract][Full Text] [Related]
19. High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts.
Lipton A; Leitzel K; Ali SM; Polimera HV; Nagabhairu V; Marks E; Richardson AE; Krecko L; Ali A; Koestler W; Esteva FJ; Leeming DJ; Karsdal MA; Willumsen N
Int J Cancer; 2018 Dec; 143(11):3027-3034. PubMed ID: 29923614
[TBL] [Abstract][Full Text] [Related]
20. Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
Schett G; Loza MJ; Palanichamy A; FitzGerald O; Ritchlin C; Bay-Jensen AC; Nielsen SH; Gao S; Hsia EC; Kollmeier AP; Xu XL; Baribaud F; Sweet K
Rheumatol Ther; 2022 Aug; 9(4):1017-1030. PubMed ID: 35352313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
